Clinical Trial Update: Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China [NA]

View source ↗

Summary

This update covers a safety and efficacy trial comparing the CYPHER sirolimus-eluting stent and the ENDEAVOR zotarolimus-eluting stent in ST-elevation myocardia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• St-elevation Myocardial Infarction

Drugs mentioned

• CYPHER Sirolimus Stent (Sirolimus-eluting stent)
• ENDEAVOR Zotarolimus Stent (Zotarolimus-eluting stent)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Myocardial Infarction, Coronary Artery Disease | NA | Status: UNKNOWN